See more : Dongguan Eontec Co., Ltd. (300328.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tikun Olam-Cannbit Pharmaceuticals Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Computer Modelling Group Ltd. (CMDXF) Income Statement Analysis – Financial Results
- Nagreeka Capital & Infrastructure Ltd. (NAGREEKCAP.BO) Income Statement Analysis – Financial Results
- Alba Mineral Resources plc (ALBA.L) Income Statement Analysis – Financial Results
- Agat Ejendomme A/S (AGAT.CO) Income Statement Analysis – Financial Results
- Husqvarna AB (publ) (HUSQ-A.ST) Income Statement Analysis – Financial Results
Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.tikun-olam.org.il
About Tikun Olam-Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, and distribution of medical cannabis and related products. It also provides training and patient care services. The company is based in Nof Hagalil, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.23M | 49.30M | 37.03M | 21.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.60M | 0.00 | 0.00 |
| Cost of Revenue | 45.99M | 52.83M | 50.09M | 22.37M | 1.07M | 362.00K | 0.00 | 701.00K | 1.07M | 557.00K | 755.00K | 780.00K | 1.89M |
| Gross Profit | -1.76M | -3.53M | -13.06M | -712.00K | -1.07M | -362.00K | 0.00 | -701.00K | -1.07M | -557.00K | 1.84M | -780.00K | -1.89M |
| Gross Profit Ratio | -3.97% | -7.17% | -35.27% | -3.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 70.92% | 0.00% | 0.00% |
| Research & Development | 3.89M | 5.16M | 7.20M | 2.16M | 634.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.25M | 3.06M | 2.96M | 7.48M | 6.15M | 593.00K | 287.00K | 197.00K | 648.00K | 184.00K | 267.00K | 330.00K | 93.00K |
| Selling & Marketing | 4.24M | 1.18M | 776.00K | 7.94M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.49M | 3.06M | 2.96M | 7.48M | 6.15M | 593.00K | 287.00K | 197.00K | 648.00K | 184.00K | 267.00K | 330.00K | 93.00K |
| Other Expenses | 77.25M | 10.10M | 9.58M | -428.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 89.63M | 13.01M | 19.55M | 31.70M | 9.58M | 20.42M | 423.00K | 197.00K | 1.74M | 3.49M | 12.59M | 19.39M | -24.31M |
| Cost & Expenses | 135.62M | 65.84M | 69.64M | 54.07M | 10.65M | 20.78M | 423.00K | 898.00K | 2.81M | 4.05M | 13.34M | 20.17M | -22.42M |
| Interest Income | 0.00 | 86.00K | 11.00K | 51.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00K | 57.00K |
| Interest Expense | 2.30M | 1.77M | 1.28M | 1.14M | 279.00K | 390.00K | 18.00K | 0.00 | 17.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 58.71M | 52.20M | 19.70M | 13.94M | 47.00K | 1.12M | 164.57K | 898.00K | 2.75M | 0.00 | -253.00K | 0.00 | 0.00 |
| EBITDA | -32.98M | 4.83M | -13.04M | -19.90M | -9.94M | 0.00 | 0.00 | 0.00 | 0.00 | -4.05M | 0.00 | -20.17M | 22.42M |
| EBITDA Ratio | -74.57% | 5.92% | -34.83% | -85.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -513.94% | 0.00% | 0.00% |
| Operating Income | -91.39M | -49.39M | -32.76M | -33.88M | -9.95M | -19.34M | -423.00K | -898.00K | -2.81M | -4.05M | -13.34M | -20.17M | 22.42M |
| Operating Income Ratio | -206.64% | -100.18% | -88.46% | -156.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -513.94% | 0.00% | 0.00% |
| Total Other Income/Expenses | -2.60M | 251.00K | -1.27M | -1.14M | -983.00K | -1.83M | -18.00K | -4.00K | -17.00K | -58.00K | -32.00K | -8.00K | -639.00K |
| Income Before Tax | -93.99M | -49.11M | -34.03M | -35.02M | -10.93M | -21.17M | -441.00K | -902.00K | -2.83M | -4.11M | -13.37M | -20.18M | 21.78M |
| Income Before Tax Ratio | -212.51% | -99.61% | -91.89% | -161.70% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -515.18% | 0.00% | 0.00% |
| Income Tax Expense | 25.00K | 12.00K | -1.22M | -273.00K | -747.00K | -1.60M | -164.57K | -898.00K | -2.75M | 0.00 | 253.00K | 0.00 | 0.00 |
| Net Income | -88.89M | -48.24M | -32.65M | -32.94M | -10.89M | -21.17M | -441.00K | -902.00K | -2.83M | -4.11M | -13.37M | -20.18M | 21.78M |
| Net Income Ratio | -200.97% | -97.85% | -88.17% | -152.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -515.18% | 0.00% | 0.00% |
| EPS | -1.41 | -0.95 | -0.73 | -0.90 | -0.56 | -2.82 | -0.07 | -7.96 | -24.95 | -37.49 | -117.15 | -178.06 | 192.12 |
| EPS Diluted | -1.41 | -0.95 | -0.73 | -0.90 | -0.56 | -2.80 | -0.07 | -7.96 | -24.95 | -37.49 | -117.15 | -178.06 | 192.12 |
| Weighted Avg Shares Out | 63.02M | 50.79M | 44.75M | 36.42M | 19.53M | 7.51M | 6.66M | 113.37K | 113.37K | 109.53K | 114.16K | 113.30K | 113.37K |
| Weighted Avg Shares Out (Dil) | 63.02M | 50.79M | 44.75M | 36.42M | 19.53M | 7.56M | 6.66M | 113.37K | 113.37K | 109.53K | 114.16K | 113.30K | 113.37K |
Source: https://incomestatements.info
Category: Stock Reports